Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
Devgn's petition stated that the notice was arbitrarily issued to him as an actor rather than to the manufacturing company
Mumbai, October 30, 2026: The Maharashtra Food and Drug Administration (FDA) is set to determine the next steps regarding a Vimal Elaichi advertisement after three Bollywood actors responded to notices issued by the regulator, FDA Commissioner Tukaram Mundhe disclosed on Tuesday. The notices were directed towards Shah Rukh Khan, Ajay Devgn and Tiger Shroff.
Responses from all three actors were received, while two of them sought individual hearings before the department, which were concluded on September 28. However, the commissioner did not specify which two actors attended the hearings. "Responses from all three have come in," Mundhe stated, noting that the hearings for the two actors were completed recently.
The Maharashtra FDA had issued notices to the actors on August 11, questioning the advertisement for potentially constituting surrogate advertising for Vimal Pan Masala, a product that is banned in the state. No final decision or penalty has been announced yet.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Ajay Devgn Moves Bombay High Court Against Maharashtra FDA Notice Over Vimal Elaichi Surrogate Advertising freepressjournal.in
- Ajay Devgn moves Bombay HC over FDA’s pan masala ad notice timesofindia.indiatimes.com
